RT - European Journal of Gynaecological Oncology ID - 10.31083/j.ejgo.2021.01.2270 T1 - Surgical approach in early stage cervical cancer: the Asian view point A1 - Hiroko Machida A1 - Hiroshi Yoshida A1 - Kenji Izumi A1 - Rie Nakajima A1 - Miwa Yasaka A1 - Tetsuji Iida A1 - Masae Ikeda A1 - Masako Shida A1 - Takeshi Hirasawa A1 - Mikio Mikami K1 - Cervical cancer; Radical hysterectomy; Minimally invasive surgery; Uterine ma-nipulator; Vaginal cuff closure; Survival YR - 2021 SP - 30 AB -

Objective: To examine the current practice of radical hysterectomy for early-stage cervical cancer in Asia after the Laparoscopic Approach to Cervical Cancer (LACC) trial. Methods: A cross-sectional study was conducted in Asia to examine the prevalence and management of women with early-stage cervical cancer. The study was conducted among gynecologic oncologists at leading hospitals in the Asian Society of Gynecologic Oncology Council members. A systematic literature review was performed to examine the association between survival outcomes and surgical approach after the LACC trial. Results: Seven countries participated voluntarily in the study. The incidence, mortality, and centralization of treatment in early-stage cervical cancer were different among the seven countries. The number of specialized centers per population density in Japan was higher than that in the other countries. Minimally invasive surgery (MIS) approach for cervical cancer was common in Korea (56%) and Hong Kong (80-90%), but not in the other countries (2-20%). In the systematic review, there was a significant difference in survival outcomes between MIS and open surgery (recurrence, hazard ratio 1.83, 95% confidence interval 1.27-2.62). MIS without a uterine manipulator or making a vaginal cuff closure produced similar recurrence rates compared with open surgery (MIS without uterine manipulator vs open-surgery: 10.5% vs 10.1%, and MIS with cuff closure vs open-surgery 7.2% vs 10.1%; all P > 0.05). Conclusion: The prevalence of MIS for early-stage cervical cancer varies across Asian regions after the LACC trial. Surgical methods to avoid tumor spillage may be useful for improving survival.